COLUMN GROUP III, LP — SEC insider filings
SEC reporting owner CIK 1668159. 50 insider filings on record with FilingPulse; latest filed 2026-10-22.
Transaction summary — filings shown
Covers all 50 filings on record, filed 2020-08-17 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 105 legs across 41 filings — 55,052,166 shares, $119,858,853 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 15 legs across 5 filings — 11,437,446 shares, $80,085,180 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 61.
- Largest priced transaction: sale of 1,075,133 shares @ $36.40 ($39,134,841) in Revolution Medicines, Inc., filed 2020-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | 10% owner | 1 | — | 2 legs · 2,027,156 sh · $73,788,478 | — |
| Tenaya Therapeutics, Inc. (TNYA) | 10% owner | 11 | 8 legs · 49,313,559 sh · $64,556,620 | 12 legs · 9,400,290 sh · $5,927,199 | 10 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 27 | 72 legs · 3,899,822 sh · $31,317,626 | — | 14 |
| Surrozen, Inc./DE (SRZN) | 10% owner | 9 | 25 legs · 1,838,785 sh · $23,984,607 | — | 35 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) | 10% owner | 2 | — | 1 leg · 10,000 sh · $369,503 | 2 |
Insider filings — COLUMN GROUP III, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-22 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Option exercise/expiry (X): 485,830 @ $11.60 · Option exercise/expiry (X): 548,653 @ $11.60 · Option exercise/expiry (X): 517,241 @ $11.60 · Option exercise/expiry (X): 728,745 (derivative) · Option exercise/expiry (X): 822,980 (derivative) · Option exercise/expiry (X): 775,861 (derivative) · +3 more | EDGAR |
| 2026-02-26 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56 | EDGAR |
| 2026-02-24 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60 | EDGAR |
| 2026-02-12 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68 | EDGAR |
| 2026-01-20 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60 | EDGAR |
| 2026-01-15 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99 | EDGAR |
| 2026-01-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89 | EDGAR |
| 2025-12-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 2,475 @ $17.35 · Purchase (P): 14,503 @ $19.54 · Purchase (P): 2,791 @ $17.35 · Purchase (P): 16,381 @ $19.54 | EDGAR |
| 2025-11-17 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 148,150 @ $12.65 · Purchase (P): 167,307 @ $12.65 | EDGAR |
| 2025-03-28 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 323,886 @ $11.60 · Purchase (P): 365,769 @ $11.60 · Purchase (P): 344,827 @ $11.60 · Code (H): 90,897 (derivative) · Purchase (P): 90,897 (derivative) · Code (H): 102,651 (derivative) · +15 more | EDGAR |
| 2025-03-07 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 35,714,284 @ $0.70 · Purchase (P): 35,714,284 (derivative) · Purchase (P): 17,857,142 (derivative) | EDGAR |
| 2024-04-17 | 4/A | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP | Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
| 2024-04-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP | Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 · Purchase (P): 90,897 (derivative) · Purchase (P): 102,651 (derivative) · Purchase (P): 98,870 (derivative) · Purchase (P): 111,656 (derivative) · +4 more | EDGAR |
| 2024-02-14 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 2,222,222 @ $4.50 | EDGAR |
| 2023-11-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62 | EDGAR |
| 2023-03-14 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 6,779 @ $2.60 | EDGAR |
| 2023-02-10 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 1,500,000 @ $2.60 | EDGAR |
| 2023-02-01 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00 | EDGAR |
| 2023-01-25 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 9,900 @ $5.00 | EDGAR |
| 2023-01-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00 | EDGAR |
| 2023-01-23 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 69,739 @ $2.50 | EDGAR |
| 2023-01-19 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 49,463 @ $2.49 · Purchase (P): 135,688 @ $2.52 | EDGAR |
| 2023-01-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 5,378 @ $4.95 | EDGAR |
| 2023-01-12 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76 | EDGAR |
| 2022-12-14 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 300 @ $4.98 | EDGAR |
| 2022-11-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00 | EDGAR |
| 2022-11-23 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 9,615,384 @ $2.60 | EDGAR |
| 2022-11-07 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72 | EDGAR |
| 2022-10-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 76,877 @ $4.86 | EDGAR |
| 2022-10-27 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85 | EDGAR |
| 2022-06-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50 | EDGAR |
| 2022-06-06 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03 | EDGAR |
| 2022-06-02 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45 | EDGAR |
| 2022-05-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45 | EDGAR |
| 2022-05-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43 | EDGAR |
| 2022-05-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48 | EDGAR |
| 2022-05-19 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20 | EDGAR |
| 2022-05-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90 | EDGAR |
| 2022-05-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 more | EDGAR |
| 2022-05-11 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36 | EDGAR |
| 2022-01-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791 | EDGAR |
| 2021-08-04 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP | Conversion (C): 4,389,282 @ $0 · Conversion (C): 4,956,842 @ $0 · Conversion (C): 3,727,742 (derivative) · Conversion (C): 4,209,755 (derivative) · Conversion (C): 472,659 (derivative) · Conversion (C): 533,781 (derivative) · +2 more | EDGAR |
| 2021-02-19 | 4 | CONSTELLATION PHARMACEUTICALS INC (CNST) jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim | Sale (S): 10,000 @ $36.95 | EDGAR |
| 2020-12-16 | 4 | CONSTELLATION PHARMACEUTICALS INC (CNST) jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim | Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Revolution Medicines, Inc. (RVMD) jointly with COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, PONOI CAPITAL, LP, Ponoi Capital II, LP, Ponoi Management, LLC, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V | Sale (S): 952,023 @ $36.40 · Sale (S): 1,075,133 @ $36.40 | EDGAR |
| 2020-09-03 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Svennilson Peter, GOEDDEL DAVID V | Purchase (P): 36,494 @ $17.64 · Purchase (P): 27,595 @ $17.67 | EDGAR |
| 2020-08-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter | Purchase (P): 36,359 @ $17.79 · Purchase (P): 26,135 @ $17.89 | EDGAR |
| 2020-08-25 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter | Purchase (P): 7,321 @ $17.97 · Purchase (P): 11,024 @ $17.96 · Purchase (P): 100 @ $18 | EDGAR |
| 2020-08-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter | Purchase (P): 19,895 @ $17.89 · Purchase (P): 37,993 @ $17.49 · Purchase (P): 6,425 @ $17.89 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1668159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs